[HTML][HTML] Stages in COVID-19 vaccine development: The Nemesis, the Hubris and the Elpis
V Nikhra - International Journal of Clinical Virology, 2020 - clinvirologyjournal.com
Conclusion: Hopes and concerns: The hope of benefiting from the vaccine to the extent that
it may be the only way to tide over and control the COVID-19 pandemic, is accompanied by …
it may be the only way to tide over and control the COVID-19 pandemic, is accompanied by …
[HTML][HTML] ГЕНЕТИКА COVID-19
ДА Вологжанин, АС Голота, ТА Камилова… - Клиническая …, 2021 - cyberleninka.ru
COVID-19 характеризуется широким спектром клинических проявлений-от
бессимптомного до крайне тяжелого. В начале пандемии стало ясно, что пожилой …
бессимптомного до крайне тяжелого. В начале пандемии стало ясно, что пожилой …
SARS-COV-2 γ variant acquires spike P681H or P681R for improved viral fitness
XJ Yang - bioRxiv, 2021 - biorxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) evolves and generates
different variants through a continuously branching model. Four variants of concern have …
different variants through a continuously branching model. Four variants of concern have …
[PDF][PDF] Evolving patterns in COVID-19: the virus, its variants and infectivity-cum-virulence
V Nikhra - Biomed J Sci Tech Res, 2021 - researchgate.net
Conclusion: Dealing with the Variants: The WHO is working with various countries to amplify
and adapt the current surveillance systems to evaluate potential virus variations through …
and adapt the current surveillance systems to evaluate potential virus variations through …
[HTML][HTML] Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis
Background Several reports on the discovery of SARS-CoV-2 mutations and variations in
Indonesia COVID-19 cases led to genomic dysregulation with the first pandemic cases in …
Indonesia COVID-19 cases led to genomic dysregulation with the first pandemic cases in …
Virological and serological characterization of critically ill patients with COVID-19 in the UK: a special focus on variant detection
J Ratcliff, D Nguyen, M Fish, J Rhynne, A Jennings… - medRxiv, 2021 - medrxiv.org
Background Treatment of COVID-19 patients with convalescent plasma containing
neutralising antibody to SARS-CoV-2 is under investigation as a means of reducing viral …
neutralising antibody to SARS-CoV-2 is under investigation as a means of reducing viral …
[PDF][PDF] Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area. mBio 11: e02707-20
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
(SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
δ1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in Europe
XJ Yang - biorxiv, 2021 - biorxiv.org
Genomic surveillance of SARS-COV-2 has revealed that in addition to many variants of
interests, this virus has yielded four variants of concern, α, β, γ and δ, as designated by the …
interests, this virus has yielded four variants of concern, α, β, γ and δ, as designated by the …
SARS-COV-2 δ variant drives the pandemic in India and Europe via two subvariants
XJ Yang - medRxiv, 2021 - medrxiv.org
ABSTRACT SARS-COV-2 evolution generates different variants and drives the pandemic.
As the current main driver, δ variant bears little resemblance to the other three variants of …
As the current main driver, δ variant bears little resemblance to the other three variants of …
[HTML][HTML] Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
CT Barrett, HE Neal, K Edmonds, CL Moncman… - bioRxiv, 2021 - ncbi.nlm.nih.gov
The SARS-CoV-2 spike protein (S) is the sole viral protein responsible for both viral binding
to a host cell and the membrane fusion event needed for cell entry. In addition to facilitating …
to a host cell and the membrane fusion event needed for cell entry. In addition to facilitating …